Display options
Cite
Pietrzak-Nowacka M, Safranow K, Bober J, et al. Calcium-phosphate metabolism parameters and erythrocyte Ca(2+) concentration in autosomal dominant polycystic kidney disease patients with normal renal function. Arch Med Sci. 2012;9(5):837-42doi: 10.5114/aoms.2012.30834.
Pietrzak-Nowacka, M., Safranow, K., Bober, J., Olszewska, M., Birkenfeld, B., Nowosiad, M., & Ciechanowski, K. (2013). Calcium-phosphate metabolism parameters and erythrocyte Ca(2+) concentration in autosomal dominant polycystic kidney disease patients with normal renal function. Archives of medical science : AMS, 9(5), 837-42. https://doi.org/10.5114/aoms.2012.30834
Pietrzak-Nowacka, Maria, et al. "Calcium-phosphate metabolism parameters and erythrocyte Ca(2+) concentration in autosomal dominant polycystic kidney disease patients with normal renal function." Archives of medical science : AMS vol. 9,5 (2013): 837-42. doi: https://doi.org/10.5114/aoms.2012.30834
Pietrzak-Nowacka M, Safranow K, Bober J, Olszewska M, Birkenfeld B, Nowosiad M, Ciechanowski K. Calcium-phosphate metabolism parameters and erythrocyte Ca(2+) concentration in autosomal dominant polycystic kidney disease patients with normal renal function. Arch Med Sci. 2013 Oct 31;9(5):837-42. doi: 10.5114/aoms.2012.30834. Epub 2012 Oct 16. PMID: 24273566; PMCID: PMC3832810.
Copy Download .nbib Format: NLM
Share it on

Arch Med Sci. 2013 Oct 31;9(5):837-42. doi: 10.5114/aoms.2012.30834. Epub 2012 Oct 16.

Calcium-phosphate metabolism parameters and erythrocyte Ca(2+) concentration in autosomal dominant polycystic kidney disease patients with normal renal function.

Archives of medical science : AMS

Maria Pietrzak-Nowacka, Krzysztof Safranow, Joanna Bober, Maria Olszewska, Bożena Birkenfeld, Monika Nowosiad, Kazimierz Ciechanowski

Affiliations

  1. Department of Nephrology, Transplantology and Internal Medicine, Pomeranian Medical University, Szczecin, Poland.

PMID: 24273566 PMCID: PMC3832810 DOI: 10.5114/aoms.2012.30834

Abstract

INTRODUCTION: The aim of this study was to assess calcium-phosphate metabolism of autosomal dominant polycystic kidney disease (ADPKD) patients with a special consideration to the following serum parameters: calcium (Ca(2+)), inorganic phosphate (Pi), parathyroid hormone (PTH) and intracellular erythrocyte calcium ([Ca(2+)]i) concentrations.

MATERIAL AND METHODS: The study included 49 adult ADPKD patients (19 males, 30 females) aged 36 ±11 years with normal renal function and no diagnosis of diabetes as well as 50 healthy controls (22 males, 28 females) matched for age and gender. Serum concentrations of sodium (Na(+)), potassium (K(+)) and magnesium (Mg(2+)) ions and Pi were determined with an indirect ion-selective method, while Ca2+ concentration was measured with a direct ion-selective method. The PTH was detected using a radioimmunometric method. [Ca(2+)]i concentration was determined with the Ca(2+) sensitive fluorescent dye Fura-2 method.

RESULTS: IN THE ADPKD GROUP, WHEN COMPARED TO CONTROLS, THE FOLLOWING CONCENTRATIONS WERE SIGNIFICANTLY HIGHER: serum Ca(2+) (1.18 ±0.06 mmol/l vs. 1.15 ±0.06 mmol/l, p = 0.0085), [Ca(2+)]i (146.9 ±110.0 nmol/l vs. 96.5 ±52.7 nmol/l, p = 0.0075), serum Na+ (139.4 ±2.7 mmol/l vs. 138.5 ±2.1 mmol/l, p = 0.060, borderline significance), and PTH (15.5 ±6.8 pg/ml vs. 13.6 ±5.3 pg/ml, p = 0.066, borderline significance), while serum Mg(2+) was significantly lower (0.81 ±0.09 mmol/l vs. 0.85 ±0.05 mmol/l, p = 0.021). In the ADPKD group we observed significant negative correlations of PTH with Ca(2+) serum concentrations (Rs = -0.32, p = 0.025) and with estimated glomerular filtration rate (Rs = -0.31, p = 0.033).

CONCLUSIONS: The erythrocyte Ca(2+) concentration is elevated in ADPKD patients with normal renal function. It may result from a dysfunction of mutated polycystins which can affect various aspects of electrolyte metabolism.

Keywords: calcium; inorganic phosphate; magnesium; parathormone; polycystins

References

  1. Nephrol Dial Transplant. 2001 Jan;16(1):85-90 - PubMed
  2. Adv Chronic Kidney Dis. 2010 Mar;17(2):153-63 - PubMed
  3. J Biol Chem. 2004 Sep 24;279(39):40419-30 - PubMed
  4. Kidney Int. 2000 Apr;57(4):1460-71 - PubMed
  5. Nephron. 1997;76(3):369-70 - PubMed
  6. Contrib Nephrol. 2011;169:247-261 - PubMed
  7. J Clin Invest. 1994 Sep;94(3):1269-76 - PubMed
  8. Am J Med Sci. 2000 Jan;319(1):10-24 - PubMed
  9. Clin Calcium. 2003 Jul;13(7):938-43 - PubMed
  10. Nephron Clin Pract. 2010;116(4):c263-8 - PubMed
  11. Cell. 1994 Jun 17;77(6):881-94 - PubMed
  12. Rev Invest Clin. 2009 Sep-Oct;61(5):364-70 - PubMed
  13. Nephrol Dial Transplant. 2009 Nov;24(11):3376-81 - PubMed
  14. Kidney Int. 1999 Jul;56(1):190-7 - PubMed
  15. J Am Soc Nephrol. 2006 Jan;17(1):178-87 - PubMed
  16. Genomics. 1993 Dec;18(3):467-72 - PubMed
  17. Lancet. 1994 Apr 2;343(8901):824-7 - PubMed
  18. Arch Med Sci. 2011 Aug;7(4):565-7 - PubMed
  19. Kidney Int. 1998 May;53(5):1343-7 - PubMed
  20. Nephrol Dial Transplant. 2003 Sep;18(9):1689-92 - PubMed
  21. Int J Artif Organs. 2000 Nov;23(11):750-3 - PubMed
  22. Nature. 2000 Dec 21-28;408(6815):990-4 - PubMed
  23. Kidney Int. 1994 Dec;46(6):1713-20 - PubMed
  24. Adv Chronic Kidney Dis. 2010 Mar;17(2):118-30 - PubMed
  25. Kidney Int. 2003 Jun;63(6):1983-94 - PubMed
  26. J Am Soc Nephrol. 2000 Jul;11(7):1179-1187 - PubMed
  27. Ter Arkh. 2009;81(8):49-52 - PubMed

Publication Types